RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 6, 2023
February 21 2023 - 3:05PM
(NASDAQ: RXST) – RxSight, Inc., an ophthalmic
medical device company dedicated to providing high quality
customized vision to patients following cataract surgery, today
announced that it will report financial results for the fourth
quarter and fiscal year 2022 after the market close on Monday,
March 6, 2023. The company’s management will discuss the results
during a conference call beginning at 1:30 p.m. Pacific Time / 4:30
p.m. Eastern Time.
Participants may register for the call here and listen through a
live and archived webcast of the event available for one year at
https://investors.rxsight.com/. While not required, it is
recommended that participants join ten minutes prior to the event
start time to ensure the necessary audio applications are
downloaded and installed. Instructions are provided (including a
dial-in option).
About RxSight, Inc.RxSight, Inc. is a
commercial-stage medical technology company dedicated to improving
the vision of patients following cataract surgery. The RxSight®
Light Adjustable Lens system, comprised of the RxSight Light
Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and
accessories, is the first and only commercially available
intraocular lens (IOL) technology that can be adjusted after
surgery enabling doctors to customize and deliver high quality of
vision to patients after cataract surgery. Additional information
about RxSight can be found at www.rxsight.com.
Company Contact:Shelley B. ThunenChief
Financial Officersthunen@rxsight.com
Investor Relations Contact:ir@rxsight.com
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Jun 2024 to Jul 2024
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Jul 2023 to Jul 2024